IDEXX Laboratories, Inc.
NASDAQ:IDXX · NASDAQ Global Select
+$12.33 today
Vol 1.05M · Avg 0.58M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+7.14%
Period High
$766.68
Period Low
$514.61
Latest
$562.09
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
argenx SE
NASDAQ:ARGX
$54.38B
Cencora, Inc.
NYSE:COR
$52.82B
Becton, Dickinson and Company
NYSE:BDX
$52.24B
Cardinal Health, Inc.
NYSE:CAH
$52.16B
Edwards Lifesciences Corporation
NYSE:EW
$50.26B
Alnylam Pharmaceuticals, Inc.
NASDAQ:ALNY
$36.93B
Agilent Technologies, Inc.
NYSE:A
$35.98B
Zoetis Inc.
NYSE:ZTS
$32.88B
IQVIA Holdings Inc.
NYSE:IQV
$27.97B
Veeva Systems Inc.
NYSE:VEEV
$24.80B
What is the latest IDXX filing?
The latest filing shown is 4 dated Jun 2, 2026.
How many recent filings does IDXX have?
Intrinsic Alpha currently shows 20 recent filings for IDXX.
Explore More
Continue the stock analysis
Jump to another research area for this company.